NCT06857487 - Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 13, 2025

Primary Completion Date

February 24, 2026

Study Completion Date

March 29, 2026

Conditions

Acute Ischemic Stroke

Interventions

DRUG

Qingre Huatan Formula

Qingre Huatan Formula, granules, 1 bag each time, twice a day, orally, continue for 10 days.

DRUG

Qingre Huatan Formula placebo

Qingre Huatan Formula placebo, granules, 1 bag each time, twice a day, orally, continue for 10 days.

OTHER

Guidelines-based standard care

Guidelines-based standard care for acute ischemic stroke

Trial Locations (1)

RECRUITING

Dongzhimen Hospital, Beijing

All Listed Sponsors

lead

Dongzhimen Hospital, Beijing

OTHER